Concepedia

Publication | Open Access

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

DOIFull Paper Access

494

Citations

24

References

2015

Year

Robert Ćhilton, I. Tikkanen, Christopher P. Cannon, S. Crowe, Hans J. Woerle, Uli C. Broedl, Odd Erik Johansen
Diabetes Obesity and Metabolism

Abstract

Empagliflozin reduced BP and had favourable effects on markers of arterial stiffness and vascular resistance.

References

YearCitations

Page 1